Crosstalk between CRISPR-Cas9 and the human transcriptome.
Aaron A Smargon, Assael A Madrigal, Brian A Yee, Kevin D Dong, Jasmine R Mueller, Gene W Yeo
Nature communications · 2022 · Vol. 13 (1) · pp. 1125
Abstract
CRISPR-Cas9 expression independent of its cognate synthetic guide RNA (gRNA) causes widespread genomic DNA damage in human cells. To investigate whether Cas9 can interact with endogenous human RNA transcripts independent of its guide, we perform eCLIP (enhanced CLIP) of Cas9 in human cells and find that Cas9 reproducibly interacts with hundreds of endogenous human RNA transcripts. This association can be partially explained by a model built on gRNA secondary structure and sequence. Critically, transcriptome-wide Cas9 binding sites do not appear to correlate with published genome-wide Cas9 DNA binding or cut-site loci under gRNA co-expression. However, even under gRNA co-expression low-affinity Cas9-human RNA interactions (which we term CRISPR crosstalk) do correlate with published elevated transcriptome-wide RNA editing. Our findings do not support the hypothesis that human RNAs can broadly guide Cas9 to bind and cleave human genomic DNA, but they illustrate a cellular and RNA impact likely inherent to CRISPR-Cas systems.
Linked datasets 1
Crosstalk between CRISPR-Cas9 and the human transcriptome
Homo sapiens
24 data files
| File | Type | Size |
|---|---|---|
| Assa_2N_S60_L005_R1_001.fastq.gz | RIP-Seq | 419.8 MB |
| Assa_2P_S61_L005_R1_001.fastq.gz | RIP-Seq | 591.4 MB |
| FLAG_CAS9_4N_S5_L001_R1_001.fastq.gz | RIP-Seq | 602.8 MB |
| FLAG_CAS9_4P_S6_L001_R1_001.fastq.gz | RIP-Seq | 681.2 MB |
| FLAG_CAS9_6N_S7_L001_R1_001.fastq.gz | RIP-Seq | 592.4 MB |
| FLAG_CAS9_6P_S8_L001_R1_001.fastq.gz | RIP-Seq | 617.6 MB |
| FLAG_pCDNA_11P_S11_L001_R1_001.fastq.gz | RIP-Seq | 610.4 MB |
| FLAG_pCDNA_12P_S12_L001_R1_001.fastq.gz | RIP-Seq | 664.2 MB |
| SRR13779885_GSM5105583 | RIP-Seq | 643.0 MB |
| SRR13779886_GSM5105584 | RIP-Seq | 686.0 MB |
| SRR13779887_GSM5105585 | RIP-Seq | 419.0 MB |
| SRR13779888_GSM5105586 | RIP-Seq | 591.0 MB |
| SRR13779889_GSM5105587 | RIP-Seq | 955.0 MB |
| SRR13779890_GSM5105588 | RIP-Seq | 644.0 MB |
| SRR13779891_GSM5105589 | RIP-Seq | 602.0 MB |
| SRR13779892_GSM5105590 | RIP-Seq | 681.0 MB |
| SRR13779893_GSM5105591 | RIP-Seq | 592.0 MB |
| SRR13779894_GSM5105592 | RIP-Seq | 617.0 MB |
| SRR13779895_GSM5105593 | RIP-Seq | 610.0 MB |
| SRR13779896_GSM5105594 | RIP-Seq | 664.0 MB |
| V5_CAS9_1N_S1_L001_R1_001.fastq.gz | RIP-Seq | 643.2 MB |
| V5_CAS9_1P_S2_L001_R1_001.fastq.gz | RIP-Seq | 686.4 MB |
| V5_pCDNA_8P_S9_L001_R1_001.fastq.gz | RIP-Seq | 955.2 MB |
| V5_pCDNA_9P_S10_L001_R1_001.fastq.gz | RIP-Seq | 644.1 MB |
Potentially related datasets 3
These accessions were text-mined from the PMC full text. They may be referenced for comparison, cited from other studies, or otherwise mentioned without being primary data for this paper.
Analysis pipelines 2
| Pipeline | Assay | Steps | Dataset |
|---|---|---|---|
| GSE167466 eCLIP Data Processing geo_data_processing | eCLIP | 18 | GSE167466 |
| GSE55887 ChIP-seq Data Processing geo_data_processing | ChIP-seq | 5 | GSE55887 |
Funding 3 grants
| Grant | Funder |
|---|---|
| R01 HG004659 | NHGRI NIH HHS (United States) |
| R01 NS103172 | NINDS NIH HHS (United States) |
| R01 EY029166 | NEI NIH HHS (United States) |